Merz Aesthetics launched a new syringe for its hyaluronic acid (HA) brand Belotero. The new syringe is ergonomically engineered to elevate the treatment experience, offering greater precision, comfort, and ease of use. The new syringe will launch first in Europe and then will expand to markets worldwide. “As the first region to introduce this innovation ahead of our global expansion, I’m proud to share this exciting milestone in Belotero’s history as a trusted leader in hyaluronic acid treatments,” says Gonzalo Mibelli, president EMEA region.
Belotero is a biomimetic hyaluronic acid (HA) treatment with a Cohesive Polydensified Matrix (CPM) gel, designed to mimic characteristics and behavior of the skin and deep layers. The brand features a full portfolio with tailored solutions to enhance facial features, improve skin quality, and reduce signs of aging, with natural-looking, long-lasting results.
With a patent-protected design developed exclusively for Belotero, the new premium syringe, with the same trusted formula, stands out in the global marketplace with several key improvements, such as:
- Ergonomic Design: The redesigned syringe offers a more comfortable grip, making handling easier during procedures.
- Precision at Every Angle: Engineered for consistent syringe performance, the syringe adapts to various angles, providing greater control and stability.
- Improved Safety Design: An integrated Luer Lock system keeps the needle securely attached, supporting safer administration.